Ypsomed opened its new tool manufacturing facility in Solothurn, thereby expanding its capacity to design and manufacture plastic injection moulds for pens and autoinjectors. In addition to its existing tool...
Ypsomed (SIX: YPSN) closed the financial year 2025/26 with consolidated revenue of CHF731.0m (prior year: CHF748.9m). Delivery Systems, the Company's core business segment, reported revenue of CHF601.5m for the period...
Ypsomed launches YpsoLoop, the first autoinjector platform designed for circularity. The two new 1ml and 2ml platform versions enable material recovery through a design enabling automated disassembly and efficient recycling,...
Visienco AG has won first prize at the Ypsomed Innovation Award 2026. The startup is developing an automated process for producing mini organs, known as organoids, which can be used...
Ypsomed (SIX: YPSN) is expanding its clinical excellence offering to support faster and more reliable clinical trials for subcutaneous injectable drugs. With CliniPilot and the Clear-to-Clinic approach, Ypsomed combines ready-to-use...
GeoStorage is reinforcing Georgia’s role as a trusted partner in global clinical trial logistics, following its participation at Clinical Trial Supply East Coast 2025 in Pennsylvania - an event focused...
In the world of clinical trials and maximizing the key outcomes possible, Data Management and Biostatistics are two critical components that often intersect. From data collection and validation to ensuring...
In a pioneering collaboration, Accelagen is joining forces with Griffith University to support a world-first Phase I clinical trial that could revolutionise the treatment of spinal cord injuries (SCI). This...
Exam Packaging launches Eco Freighter, a circular cold chain solution for pharmaceutical logistics that delivers uncompromised product quality with lower costs and measurable climate benefits. Its lightweight-in-use design reduces transport...
Accelagen’s medical team is growing, strengthening our capabilities in pharmacovigilance, medical writing, and clinical oversight for safer, smarter trials. Accelagen is in an exciting phase of growth, with our medical...
